TY  - GEN
AU  - Bennett,Jason W
AU  - Yadava,Anjali
AU  - Tosh,Donna
AU  - Sattabongkot,Jetsumon
AU  - Komisar,Jack
AU  - Ware,Lisa A
AU  - McCarthy,William F
AU  - Cowden,Jessica J
AU  - Regules,Jason
AU  - Spring,Michele D
AU  - Paolino,Kristopher
AU  - Hartzell,Joshua D
AU  - Cummings,James F
AU  - Richie,Thomas L
AU  - Lumsden,Joanne
AU  - Kamau,Edwin
AU  - Murphy,Jittawadee
AU  - Lee,Cynthia
AU  - Parekh,Falgunee
AU  - Birkett,Ashley
AU  - Cohen,Joe
AU  - Ballou,W Ripley
AU  - Polhemus,Mark E
AU  - Vanloubbeeck,Yannick F
AU  - Vekemans,Johan
AU  - Ockenhouse,Christian F
TI  - Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
SN  - 1935-2735
PY  - 2016///0720
KW  - Adolescent
KW  - Adult
KW  - Antibodies, Protozoan
KW  - immunology
KW  - Female
KW  - Humans
KW  - Malaria Vaccines
KW  - administration & dosage
KW  - Malaria, Vivax
KW  - Male
KW  - Middle Aged
KW  - Plasmodium vivax
KW  - Protozoan Proteins
KW  - Vaccination
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1371/journal.pntd.0004423
ER  -